glp 1 with hashimoto's disease and GLP-1: what thyroid patients need to know before starting Hashimoto's and Semaglutide: Safety and
Description
Una revolucin en el tratamiento metablico
[Abstract]2024 Sep 12;15(1):7991
For example, the studies included in this meta-analysis involved varying the patient profiles, some of which included patients with more advanced metabolic disease conditions, potentially influencing the degree of weight reduction observed
PGC: OR = 0.71, 95% CI [0.580.87]
It is often prescribed to patients who have not had success with or experienced unwanted side effects from other antidepressants, such as selective serotonin reuptake inhibitors (SSRIs)
Lancet, 2022
